Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin 150 mg versus 75 mg for prevention of preterm preeclampsia in high-risk pregnant women in Abuja
PACTR202312795734215Not yet recruiting
- Sponsor
- Dr. Suraiya Auwal Suleiman
- Start
- Dec 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of aspirin in preeclampsia (2 arms), sponsored by Dr. Suraiya Auwal Suleiman. Primary endpoints: Preeclampsia and Preeclampsia-associated fetal growth restriction. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on PACTR202312795734215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202312795734215.